Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
-
Published:2024-05-15
Issue:6
Volume:30
Page:1612-1621
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Wu XiaohuaORCID, Liu Jihong, Wang Jing, Wang Li, Lin Zhongqiu, Wang Xiaobin, Zhu Jianqing, Kong Beihua, Fei Junwei, Tang Ying, Xia Bairong, Liang Zhiqing, Wang Ke, Huang Yi, Zheng Hong, Lin An, Jiang Kui, Wang Wei, Wang Xin, Lou Ge, Pan Hongming, Yao Shuzhong, Li Guiling, Hao Min, Cai Yunlang, Chen Xuejun, Yang Zhijun, Chen Youguo, Wen Hongwu, Qu Pengpeng, Xu Cong, Hsieh Chih-Yi, , Cui Manhua, Chen Lipai, Cheng Ying, Zhao Weidong, Pan Mei, Tang Yaling, Zhang Yu, Lin Xiaoyan, Abulizi Guzhalinuer, Duan Wei, Zeng Linjuan
Funder
This study was funded by IMPACT Therapeutics (Shanghai) Inc
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). 2. National Cancer Institute. Cancer stat facts: ovarian cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program 2013–2019 https://seer.cancer.gov/statfacts/html/ovary.html (2019). 3. National Comprehensive Cancer Network. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer, version 2.2023. NCCN https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf (2022). 4. Berek, J. S., Renz, M., Kehoe, S., Kumar, L. & Friedlander, M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int. J. Gynaecol. Obstet. 155, 61–85 (2021). 5. González-Martín, A. et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34, 833–848 (2023).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|